Chapter 57: Weight Loss Flashcards
Overweight is what BMI?
25-29
Obese is what BMI?
> 30
Drugs/Conditions that can cause weight gain
- Antipsychotics (clozapine, olanzapine, risperidone, quetiapine)
- Diabetes drugs (insulin, meglitinides, sulfonylureas, TZDs)
- Divalproex/valproic acid
- Gabapentin/pregabalin
- Lithium
- Mirtazapine
- Steroids
- TCAs
- Hypothyroidism
Drugs/Conditions that can cause weight loss
- ADHD drugs
- Bupropion
- GLP-1 agonists
- Pramlintide
- Roflumilast
- SGLT2 inhibitors
- Topiramate
- Hyperthyroidism
- Celiac disease
- IBS
Weight loss drugs in pregnancy?
Avoid all
Weight loss drugs with hypertension?
Avoid Contrave (CI with uncontrolled BP) Caution with Qsymia (monitor HR)
Weight loss drugs with depression?
Caution in young adults and adolescents
Contrave- suicide risk (bupropion)
Weight loss drugs with seizures?
Avoid Contrave (lowers seizure threshold) Caution Qsymia (must taper off slowly [topiramate])
Weight loss drugs and taking opioids?
Avoid Contrave (blocks opioid receptors, contain naltrexone)
Phentermine MOA
Sympathomimetic (stimulant); release of NE stimulates the satiety center which decreases appetite
Topiramate MOA
Increases satiety and decreases appetite, possible by increasing GABA, blocking glutamate receptors and/or inhibition or carbonic anhydrase
Qsymia
phentermine and topiramate
REMs due to teratogenicity (-pregnancy test required)
CIs: pregnancy, glaucoma, hyperthyroidism, MAOi w/i 14 days
Naltrexone MOA
Decreases food cravings
Bupropion MOA
Decreases appetite
Contrave
Naltrexone/Bupropion
BOXED WARNING: not approved for treatment of MDD or psychiatric disorders; can increase risk of suicidal thinking/behavior in children, adolescents, and young adults; not approved in pediatric patients
Contrave CIs
- Pregnancy
- Opioid use or acute opioid withdrawal
- Uncontrolled HTN
- Seizure disorder
- Use of other bupropion containing products
- Bulemia/anorexia
- Abrupt d/c of alcohol, benzos, barbiturates, antiepileptics
- Use of MAOi in 14 days
GLP-1 receptor agonist MOA
Increases satiety
saxenda (liraglutide) CIs
Victoza-diabetes
- Pregnancy
- Personal or family history of medullary thyroid carcinomas, or patients with multiple endocrine, neoplasia syndrome type 2
Saxenda warnings
- pancreatitis
- hypoglycemia
- acute gallbladder disease
- gastroparesis
Lipase inhibitor MOA
Decreases absorption of dietary fats by about 30%
Orlistat CIs
xenical-rx, alli- otc
- Pregnancy
- Chronic malabsorption syndrome
- cholestasis
- not CI but must be used with a low fat diet*
Appetite suppressants and MOA
MOA: sympathomimetics (stimulants); release of NE stimulates the satiety center with decreases appetit
- phentermine (C-IV)
- Diethylpropion (C-IV)
- Phendimetrazine (C-III)
- Benzphetamine (C-III)
Stimulant CIs
- Cardiovascular disease (uncontrolled htn, arrhythmias, hf, cad)
- hyperthyroidism
- glaucoma
- pregnancy
- breast feeding
- hx of drug abuse
- MAOi’s w/in 14 days
When is bariatric surgery recommened?
When BMI >=40 or when BMI >=35 and obesity related condition
Common nutrient deficiencies with bariatric surgery
- Calcium (absorbed in duodenum) citrate is preferred
- Anemia from B-12 and iron deficiency
- ADEK (fat-soluble vitamins)